Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: Low doses induce hypolocomotion

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 2, 2012, Pages 230-236

  Singh, Rana A K ^a,b   Kosten, Therese A ^a,b   Kinsey, Berma M ^a,b   Shen, Xiaoyun ^a,b   Lopez, Angel Y ^a,b   Kosten, Thomas R ^a,b   Orson, Frank M ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hyperlocomotion; Hypolocomotion; Methamphetamine; Mice; Stereotypy

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; DESENSITIZATION; DRUG DEPENDENCE; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; HYPERLOCOMOTION; HYPOLOCOMOTION; LOCOMOTION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LOCOMOTION; METHAMPHETAMINE; MICE; MICE, INBRED BALB C;

MUS;

EID: 84866281907     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.08.013     Document Type: Article

References (48)

1. P.H. Andersen, and J.A. Jansen Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy Eur J Pharmacol 188 1990 335 347
2. T. Archer, and A. Fredriksson Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose-, time- and parameter-dependency Neurotox Res 1 2000 235 247
3. E. Bartlett, A. Hallin, B. Chapman, and B. Angrist Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology 16 1997 77 82
4. K.A. Byrnes-Blake, E.M. Laurenzana, R.D. Landes, W.B. Gentry, and S.M. Owens Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats Eur J Pharmacol 521 2005 86 94
5. I. Creese, and S.D. Iversen The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat Psychopharmacologia 39 1974 345 357
6. J.R. Daniels, W.D. Wessinger, W.C. Hardwick, M. Li, M.G. Gunnell, and C.J. Hall Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons Psychopharmacology (Berl) 185 2006 36 44
7. G. Dore, and M. Sweeting Drug-induced psychosis associated with crystalline methamphetamine Australas Psychiatry 14 2006 86 89
8. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu Rev Pharmacol Toxicol 47 2007 681 698
9. W.B. Gentry, A.U. Ghafoor, W.D. Wessinger, E.M. Laurenzana, H.P. Hendrickson, and S.M. Owens (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration Pharmacol Biochem Behav 79 2004 751 760
10. F.R. George Cocaine produces low dose locomotor depressant effects in mice Psychopharmacology (Berl) 99 1989 147 150
11. F.R. George Cocaine produces low dose locomotor depressant effects in NBR and F344 rats Pharmacol Biochem Behav 37 1990 795 798
12. R.Z. Goldstein, and N.D. Volkow Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex Am J Psychiatry 159 2002 1642 1652
13. W. Haning, and D. Goebert Electrocardiographic abnormalities in methamphetamine abusers Addiction 102 Suppl. 1 2007 70 75
14. D. Harris, and S.L. Batki Stimulant psychosis: symptom profile and acute clinical course Am J Addict 9 2000 28 37
15. D.J. Heal, M.R. Prow, and W.R. Buckett Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic alpha 2-adrenoceptors in the brain Eur J Pharmacol 170 1989 19 28
16. M. Irifune, M. Nomoto, and T. Fukuda Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine Eur J Pharmacol 272 1995 79 85
17. Y. Itzhak, and S.F. Ali Behavioral consequences of methamphetamine- induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction Ann N Y Acad Sci 965 2002 127 135
18. S.D. Iversen, and S.T. Mason Proceedings: Impaired response control in the rat after 6-hydroxydopamine lesions to the dorsal noradrenaline bundles Br J Pharmacol 55 1975 293P
19. S.D. Iversen, P.H. Kelly, R.J. Miller, and P. Seviour Proceedings: Amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones Br J Pharmacol 54 1975 244P
20. L. Karila, A. Weinstein, H.J. Aubin, A. Benyamina, M. Reynaud, and S.L. Batki Pharmacological approaches to methamphetamine dependence: a focused review Br J Clin Pharmacol 69 2010 578 592
21. J.W. Kebabian, and D.B. Calne Multiple receptors for dopamine Nature 277 1979 93 96
22. K. Kitahama, and J.L. Valatx Strain differences in amphetamine sensitivity in mice. I. A diallel analysis of open field activity Psychopharmacology (Berl) 66 1979 189 194
23. T.R.N.T. Kosten, R. De La Garza, and C.N. Haile Cocaine and Methamphetamine Dependence: Advances in Treatment 2012 American Psychiatric Publishing Washington, DC
24. K. Lapworth, S. Dawe, P. Davis, D. Kavanagh, R. Young, and J. Saunders Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users Addict Behav 34 2009 380 385
25. J.C. Maxwell Emerging research on methamphetamine Curr Opin Psychiatry 18 2005 235 242
26. R.T. McCabe, G.R. Hanson, T.M. Dawson, J.K. Wamsley, and J.W. Gibb Methamphetamine-induced reduction in D1 and D2 dopamine receptors as evidenced by autoradiography: comparison with tyrosine hydroxylase activity Neuroscience 23 1987 253 261
27. U.D. McCann, H. Kuwabara, A. Kumar, M. Palermo, R. Abbey, and J. Brasic Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users Synapse 62 2008 91 100
28. R. McKetin, J. McLaren, D.I. Lubman, and L. Hides The prevalence of psychotic symptoms among methamphetamine users Addiction 101 2006 1473 1478
29. D.E. McMillan, W.C. Hardwick, M. Li, M.G. Gunnell, F.I. Carroll, and P. Abraham Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat J Pharmacol Exp Ther 309 2004 1248 1255
30. A. Milesi-Halle, D.E. McMillan, E.M. Laurenzana, K.A. Byrnes-Blake, and S.M. Owens Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats Pharmacol Biochem Behav 86 2007 140 149
31. T. Nishikawa, N. Mataga, M. Takashima, and M. Toru Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment Eur J Pharmacol 88 1983 195 203
32. F.M. Orson, B.M. Kinsey, R.A. Singh, Y. Wu, T. Gardner, and T.R. Kosten Substance abuse vaccines Ann N Y Acad Sci 1141 2008 257 269
33. F.C. Pereira, E.S. Lourenco, F. Borges, T. Morgadinho, C.F. Ribeiro, and T.R. Macedo Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen Synapse 60 2006 185 193
34. R.A. Rawson, R. Gonzales, V. Pearce, A. Ang, P. Marinelli-Casey, and J. Brummer Methamphetamine dependence and human immunodeficiency virus risk behavior J Subst Abuse Treat 35 2008 279 284
35. G.J. Riviere, K.A. Byrnes, W.B. Gentry, and S.M. Owens Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat J Pharmacol Exp Ther 291 1999 1220 1226
36. T. Robbins, and S.D. Iversen A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats Psychopharmacologia 28 1973 155 164
37. T.E. Robinson, and K.C. Berridge Review. The incentive sensitization theory of addiction: some current issues Philos Trans R Soc Lond B Biol Sci 363 2008 3137 3146
38. R.B. Rothman, M.H. Baumann, C.M. Dersch, D.V. Romero, K.C. Rice, and F.I. Carroll Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 2001 32 41
39. X. Shen, C. Purser, L.T. Tien, C.T. Chiu, I.A. Paul, and R. Baker mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization J Neurosci Res 88 2010 2294 2302
40. S. Shoptaw, J. Peck, C.J. Reback, and E. Rotheram-Fuller Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment J Psychoactive Drugs 35 Suppl. 1 2003 161 168
41. M. Sofuoglu, and R.A. Sewell Norepinephrine and stimulant addiction Addict Biol 14 2009 119 129
42. S. Vergo, J.L. Johansen, M. Leist, and J. Lotharius Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels Brain Res 1185 2007 18 32
43. O. Vigil, S.P. Woods, L.M. Moran, S.L. Letendre, C. Young-Casey, and I. Grant Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence? Am J Addict 16 2007 418 423
44. N.D. Volkow, and T.K. Li Drug addiction: the neurobiology of behaviour gone awry Nat Rev Neurosci 5 2004 963 970
45. N.D. Volkow, G.J. Wang, J.S. Fowler, P.P. Thanos, J. Logan, and S.J. Gatley Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study Synapse 46 2002 79 82
46. T.J. Volz, A.E. Fleckenstein, and G.R. Hanson Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment Addiction 102 Suppl. 1 2007 44 48
47. D. Weinshenker, and J.P. Schroeder There and back again: a tale of norepinephrine and drug addiction Neuropsychopharmacology 32 2007 1433 1451
48. M.H. Yang, S. Kim, M.S. Jung, J.H. Shim, N.K. Ryu, and Y.J. Yook Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system Addict Biol 13 2008 287 294